Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma.
J Cancer Res Ther
; 14(5): 1149-1151, 2018.
Article
en En
| MEDLINE
| ID: mdl-30197367
ABSTRACT
Due to the cytotoxic effects of old chemotherapy regimens used in the islet cell tumors, capecitabine plus temozolomide combination has now become the first choice in the treatment of malignant insulinoma (MIoma). We present this case to emphasize and remind that a durable complete response in advanced stage MIoma may be achieved with a short course of streptozotocin plus doxorubicin combination.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Doxorrubicina
/
Estreptozocina
/
Adenoma de Células de los Islotes Pancreáticos
/
Insulinoma
/
Neoplasias Hepáticas
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Cancer Res Ther
Asunto de la revista:
NEOPLASIAS
/
TERAPEUTICA
Año:
2018
Tipo del documento:
Article
País de afiliación:
Turquía